Pituitary failure,metformin and hypoglycaemia in type 2 diabetes

Abstract

Get full access to this article

View all access options for this article.

References

UK Prospective Diabetes Study (UKPDS) Group. Effects of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.

Jones GC , Macklin JP , Alexander WD Contraindications to the use of metformin. BMJ 2003;326:4-5.

Tattersall RB Frequency, causes and treatment of hypoglycaemia. In: Frier BM and Fisher BM (eds), Hypoglycaemia in clinical diabetes. 1999. Chichester: Wiley and Sons : pp 55-87.

Salpeter S. , Greyber E. , Pasternak G. , Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Cochrane Review). Cochrane Database Syst Rev 2003;(2):CD002967.

Howlett HCS , Bailey CJ A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety 1999 ;20:489-503.

Seltzer HS Drug-induced hypoglycaemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989;18(1):163-83.